RO7496998
CV43043
Phase 3 small_molecule terminated
Quick answer
RO7496998 for COVID-19 is a Phase 3 program (small_molecule) at Atea Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Atea Pharmaceuticals
- Indication
- COVID-19
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- terminated